Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Histopathologic and Clinical Evaluation of Patients Undergoing Carpal Tunnel Release With Risk Markers for Amyloidosis

NCT05793320 is registered in ClinicalTrials.gov with Henry Ford Health System as lead sponsor.

NCT NCT05793320
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05793320 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Histopathologic and Clinical Evaluation of Patients Undergoing Carpal Tunnel Release With Risk Markers for Amyloidosis
Lead sponsor
Henry Ford Health System
Phase
Not applicable
Overall status
Completed
Start date
August 3, 2023
Completion date
December 4, 2025
Enrollment
250 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

amyloidosis